Parise, E., Cheinquer, H., Crespo, D., Meirelles, A., Martinelli, A., Sette, H., . . . Pessoa, M. Peginterferon alfa-2a (40KD) (PEGASYS®) plus ribavirin (COPEGUS®) in retreatment of chronic hepatitis C patients, nonresponders and relapsers to previous conventional interferon plus ribavirin therapy. Elsevier.
Chicago Style (17th ed.) CitationParise, E., et al. Peginterferon Alfa-2a (40KD) (PEGASYS®) Plus Ribavirin (COPEGUS®) in Retreatment of Chronic Hepatitis C Patients, Nonresponders and Relapsers to Previous Conventional Interferon Plus Ribavirin Therapy. Elsevier.
MLA (8th ed.) CitationParise, E., et al. Peginterferon Alfa-2a (40KD) (PEGASYS®) Plus Ribavirin (COPEGUS®) in Retreatment of Chronic Hepatitis C Patients, Nonresponders and Relapsers to Previous Conventional Interferon Plus Ribavirin Therapy. Elsevier.